Awign is India’s largest tech-led, on-demand work fulfilment platform, enabling enterprises to execute recurring, outcome-based business tasks at scale. The platform provides end-to-end, technology-driven management of gig work, allowing companies to variabilise fixed manpower costs while ensuring transparent, quality-assured, and on-time execution. Awign supports over 175 enterprises and is a leading enterprise partner for seller verification and onboarding across platforms such as ONDC, Amazon, and other major e-commerce marketplaces.
Built on an asset-light, highly configurable tech stack, Awign mobilises and manages a pan-India gig workforce in real time. Its use cases span digital work such as online proctoring and content moderation, and offline operations including seller verification, retail and mystery audits, business development, and last-mile delivery. The platform also supports white-collar engagements through Awign Expert. To date, Awign has enabled income opportunities for over 1.5 million gig workers and is expanding internationally, with the Middle East as its next market.
Awign was founded in 2016 by IIT Ropar alumni Anannya Sarthak, Gurpreet Singh, and Praveen Kumar.
LabInApp delivers fully interactive 3-D virtual science labs, enabling students and teachers to simulate physics, chemistry, biology, and math experiments on computers or mobile devices, regardless of whether a school has a physical lab.
By enabling immersive, curriculum-aligned practical learning in low-infrastructure or resource-constrained schools, LabInApp scales practical science education across educational institutions, making science accessible, engaging, and affordable at scale.
Founded in 2015, LabInApp was founded by Pavan Shinde, Girish Shirigannavar, Pramod Ramdurg, and Vinayak Hulabutti, a team with strong engineering roots in computer graphics and software development. The founders bring complementary strengths across product architecture, 3-D simulation technology, and execution in education-focused software. The company was acquired by BYJU’s in 2020.
Predible Health builds AI‑powered radiology software to help hospitals and imaging centers diagnose liver and lung diseases faster and more accurately. Their flagship products, Predible Liver and Predible Lung, use cloud‑native deep learning algorithms to automatically analyze CT/scan data, detect anomalies, and generate 3D visualizations and malignancy assessments. The platform aims to expand access to quality diagnostics across India and emerging markets by enabling radiologists to handle larger imaging volumes with improved consistency and speed.
Predible Health was founded by Suthirth Vaidya, Abhijith Chunduru, and Deepak Mohan. Suthirth holds an MTech from IIT Madras, worked on deep learning for medical imaging at the Biomedical Imaging Lab, and has prior experience at Philips Healthcare. Abhijith brings a strong research background in machine learning for radiology, with academic work focused on deep learning-based imaging models. Deepak holds a BTech in Mechanical Engineering from IIT Madras and an MBA from IIM Ahmedabad, and previously worked at Bosch India before co-founding the company.
Predible Health was acquired by nference in 2022.
UE LifeSciences builds portable, non-invasive cancer-screening devices, like iBreastExam and cervAIcal, that allow community health workers to detect breast and cervical cancer early, even in low-resource or underserved settings. By pairing medical-grade diagnostics with affordability and simple deployment, UE LifeSciences makes cancer detection accessible at scale, helping catch cases that would otherwise go unnoticed until advanced stages.
UE LifeSciences’ iBreastExam device has enabled over 2 million breast exams across 12+ countries, detecting cancers early, with clinical validation from over 25,000 women.
Founded in 2009, UE LifeSciences was started by Mihir Shah and Matthew Campisi, with Bhaumik Sanghvi later joining the founding leadership team to lead India operations. Shah and Campisi bring complementary strengths in medical device innovation and engineering. The investment was exited via a founder-led buyback in 2021.
Welcare is a tele-ophthalmology platform delivering affordable eye screening through an in-hospital specialty clinic model embedded within existing healthcare facilities. Using low-cost digital screening devices and remote diagnosis, Welcare enables fast-turnaround detection of conditions like diabetic retinopathy across high-footfall urban, tier-2/3, and rural clinics, creating incremental revenue for providers and giving patients convenient, low-cost access to eye care.
Founded in 2012 by Dr Tamilarasan Senthil, an ophthalmologist with seven years of experience running an ophthalmology and laser surgery hospital in Chennai.
India Fund I AIF exited Welcare at a valuation of INR 5.2 Cr., delivering a MOIC of 2.03x and an IRR of 20.21%.
Capria Ventures and its related entities are committed to the highest standards of ethics and strictly enforce a zero-tolerance anti-corruption policy. Please report any suspicious activity to grievance@capria.vc. All reports will be treated with utmost urgency and resolved appropriately.
Unitus Ventures, a leading venture capital firm in India, is joining forces with its US affiliate Capria Ventures, a Global South specialist, to operate with a unified global strategy under a single brand, Capria Ventures.
